GlobeStar Therapeutics Co. (OTCMKTS:GSTC) Short Interest Update

GlobeStar Therapeutics Co. (OTCMKTS:GSTC) was the recipient of a large decrease in short interest in February. As of February 15th, there was short interest totalling 3,200 shares, a decrease of 91.0% from the January 31st total of 35,600 shares. Based on an average trading volume of 10,934,400 shares, the short-interest ratio is presently 0.0 days.

GlobeStar Therapeutics Trading Up 50.0 %

GSTC traded up $0.00 during trading on Friday, hitting $0.00. 24,644 shares of the company’s stock traded hands, compared to its average volume of 4,093,090. GlobeStar Therapeutics has a 12-month low of $0.00 and a 12-month high of $0.00.

GlobeStar Therapeutics Company Profile

GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. It offers Amethyst, a compound intended to treat neurodegeneration. The company was formerly known as AngioSoma, Inc and changed its name to GlobeStar Therapeutics Corporation in July 2021.